Page last updated: 2024-11-05

tropicamide and Panuveitis

tropicamide has been researched along with Panuveitis in 1 studies

Tropicamide: One of the MUSCARINIC ANTAGONISTS with pharmacologic action similar to ATROPINE and used mainly as an ophthalmic parasympatholytic or mydriatic.

Panuveitis: Inflammation in which both the anterior and posterior segments of the uvea are involved and a specific focus is not apparent. It is often severe and extensive and a serious threat to vision. Causes include systemic diseases such as tuberculosis, sarcoidosis, and syphilis, as well as malignancies. The intermediate segment of the eye is not involved.

Research Excerpts

ExcerptRelevanceReference
"After 7 months of treatment for bilateral panuveitis with topical steroid and tropicamide, the patient developed a thin, transparent membrane arising on the lens surface in the right eye."3.70True exfoliation of the lens capsule following uveitis. ( Miyagawa, A; Yamamoto, N, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamamoto, N1
Miyagawa, A1

Other Studies

1 other study available for tropicamide and Panuveitis

ArticleYear
True exfoliation of the lens capsule following uveitis.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2000, Volume: 238, Issue:12

    Topics: Acetazolamide; Aged; Betamethasone; Drug Therapy, Combination; Exfoliation Syndrome; Female; Humans;

2000